Extended Data Table 3 Primary analysis hypothesis 2. Absolute unadjusted values for HbA1c on sitagliptin and canagliflozin split by eGFR strata and the corresponding mean difference between drugs, and between strata. P value assessed by a t test comparing the difference between drugs between strata. *negative values favour sitagliptin

From: Patient stratification for determining optimal second-line and third-line therapy for type 2 diabetes: the TriMaster study